Overview

Study of S-1 in Combination With Radiotherapy in Esophageal Cancer

Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
This trial aims to study the safety, the local control, and the overall survival of S-1 combined with radiotherapy for patients with esophageal squamous cell carcinoma. 105 patients will be recruited into this trial.
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University